Get started
LeMaitre Vascular, Inc.LeMaitre Vascular, Inc.LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

LMAT chart


Full chart

LMAT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.27 B‬ USD
Dividend yield (indicated)
0.63%
Price to earnings Ratio (TTM)
55.35
Basic EPS (TTM)
1.84 USD
Net income (FY)
‪30.11 M‬ USD
Revenue (FY)
‪193.48 M‬ USD
Shares float
‪20.45 M‬
Beta (1Y)
0.87

Employees


Employees (FY)
630
Change (1Y)
+13 +2.11%
Revenue / Employee (1Y)
‪307.12 K‬ USD
Net income / Employee (1Y)
‪47.79 K‬ USD

About LeMaitre Vascular, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
George W. LeMaitre
Website
lemaitre.com
Headquarters
Burlington
Founded
1983
FIGI
BBG000LY1HS2
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LMAT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LMAT highest yielding bonds


LMAT5964284
LeMaitre Vascular, Inc. 2.5% 01-FEB-2030
Yield to maturity
—
Maturity date
Feb 1, 2030

Explore more bonds 

Frequently Asked Questions


The current price of LMAT is 99.54 USD — it has decreased by −1.37% in the past 24 hours. Watch LeMaitre Vascular, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LeMaitre Vascular, Inc. stocks are traded under the ticker LMAT.
LMAT stock has risen by 2.72% compared to the previous week, the month change is a −0.21% fall, over the last year LeMaitre Vascular, Inc. has showed a 58.43% increase.
We've gathered analysts' opinions on LeMaitre Vascular, Inc. future price: according to them, LMAT price has a max estimate of 117.00 USD and a min estimate of 85.00 USD. Watch LMAT chart and read a more detailed LeMaitre Vascular, Inc. stock forecast: see what analysts think of LeMaitre Vascular, Inc. and suggest that you do with its stocks.
LMAT reached its all-time high on Nov 25, 2024 with the price of 109.58 USD, and its all-time low was 1.54 USD and was reached on Feb 19, 2009. View more price dynamics on LMAT chart.
See other stocks reaching their highest and lowest prices.
LMAT stock is 2.61% volatile and has beta coefficient of 0.87. Track LeMaitre Vascular, Inc. stock price on the chart and check out the list of the most volatile stocks — is LeMaitre Vascular, Inc. there?
Today LeMaitre Vascular, Inc. has the market capitalization of ‪2.27 B‬, it has decreased by −1.61% over the last week.
Yes, you can track LeMaitre Vascular, Inc. financials in yearly and quarterly reports right on TradingView.
LeMaitre Vascular, Inc. is going to release the next earnings report on Feb 24, 2025. Keep track of upcoming events with our Earnings Calendar.
LMAT earnings for the last quarter are 0.49 USD per share, whereas the estimation was 0.43 USD resulting in a 12.64% surprise. The estimated earnings for the next quarter are 0.49 USD per share. See more details about LeMaitre Vascular, Inc. earnings.
LeMaitre Vascular, Inc. revenue for the last quarter amounts to ‪54.82 M‬ USD, despite the estimated figure of ‪53.50 M‬ USD. In the next quarter, revenue is expected to reach ‪55.98 M‬ USD.
LMAT net income for the last quarter is ‪11.14 M‬ USD, while the quarter before that showed ‪11.83 M‬ USD of net income which accounts for −5.79% change. Track more LeMaitre Vascular, Inc. financial stats to get the full picture.
Yes, LMAT dividends are paid quarterly. The last dividend per share was 0.16 USD. As of today, Dividend Yield (TTM)% is 0.63%. Tracking LeMaitre Vascular, Inc. dividends might help you take more informed decisions.
LeMaitre Vascular, Inc. dividend yield was 0.99% in 2023, and payout ratio reached 41.71%. The year before the numbers were 1.09% and 53.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 22, 2025, the company has 630.00 employees. See our rating of the largest employees — is LeMaitre Vascular, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LeMaitre Vascular, Inc. EBITDA is ‪59.21 M‬ USD, and current EBITDA margin is 24.08%. See more stats in LeMaitre Vascular, Inc. financial statements.
Like other stocks, LMAT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LeMaitre Vascular, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LeMaitre Vascular, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LeMaitre Vascular, Inc. stock shows the buy signal. See more of LeMaitre Vascular, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.